OUM & Co

OUM's life sciences practice professionals have the expertise, resources and relationships to help both public and private life science companies bridge the gap between business and science in today's complex and volatile business environment. In the push to bring new products to market, companies from startups to multinationals must address a myriad of challenges, both financial and nonfinancial.

OUM’s life sciences group serves publicly traded and privately held companies in the biotechnology, pharmaceuticals, medical device, biopharma, and diagnostic sectors, among others. We understand the need to manage for immediate and long-term value in the face of lengthy, high-cost research and development cycles, government approvals, and difficult clinical trials.

With decades of experience working with both public and private life sciences companies, and the support of a National Office, we have the technical experience needed to provide world class service. In addition to providing the traditional tax and accounting services, we also assist our life sciences clients with services spanning the entire development cycle of companies.

Our experience enables us to provide the following services:

  • Integrated audits of financial statements and internal control over financial reporting for public companies
  • Audits of financial statements for public companies that are non-accelerated filers
  • Financial statement audits, reviews, and compilations for privately held companies
  • Assistance and technical research throughout the initial public offering process
  • Assisting with capital market financing transactions - as independent auditors, we have participated in over 100 public and private offerings totaling more than $2.5 billion since 2005
  • Accounting guidance on complex or unusual transactions, such as revenue recognition for collaborative agreements, debt and equity financings, and business combinations
  • Financial due diligence for mergers and acquisitions and divestitures
  • Federal and state corporate income tax compliance
  • Income tax provisions and analysis of uncertain tax positions
  • Change of Ownership Analysis (IRC Section 382 Studies)
  • Consulting on tax matters, including deferred compensation issues under IRC Section 409A, intercompany transfer pricing, tax planning strategies and international taxation
  • Audits of 401K Plans